Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI India 2024CPhI India 2024
Not Confirmed
Not Confirmed
26-28 November, 2024
Not Confirmed
Not Confirmed
03-06 November, 2024
2024 ACI Convention2024 ACI Convention
Not Confirmed
Not Confirmed
03-07 November, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI India 2024CPhI India 2024
Industry Trade Show
Not Confirmed
26-28 November, 2024
Industry Trade Show
Not Confirmed
03-06 November, 2024
2024 ACI Convention2024 ACI Convention
Industry Trade Show
Not Confirmed
03-07 November, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/due-to-its-20-year-mastery-in-micronization-inke-has-emerged-a-cornerstone-in-treating-global-respiratory-diseases
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/dmf-filings-hit-all-time-high-in-q3-2024-china-tops-list-with-58-increase-in-type-ii-submissions
04 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/04/2940233/0/en/Actimed-Therapeutics-Announces-US-FDA-Grant-of-Orphan-Drug-Designation-to-S-oxprenolol-ACM-002-for-the-Treatment-of-Amyotrophic-Lateral-Sclerosis-ALS.html
19 Oct 2023
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2023/10/19/2762896/0/en/Actimed-Therapeutics-Appoints-Martin-Walton-as-Chief-Financial-Officer.html
07 Sep 2023
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2023/09/07/2739001/0/en/Actimed-Therapeutics-announces-FDA-approval-of-its-Investigational-New-Drug-application-for-Phase-2b-3-IMPACT-clinical-trials-of-S-pindolol-benzoate-to-treat-cancer-cachexia.html
26 Jun 2023
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2023/06/26/2694141/0/en/Actimed-Therapeutics-closes-over-subscribed-Series-A-Financing-Round-of-5-million-to-advance-clinical-development-of-lead-programme-for-cancer-cachexia.html
04 Jan 2023
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/actimed-therapeutics-successfully-closes-second-tranche-of-10m-seed-financing-to-progress-pipeline-for-treatment-of-cancer-cachexia-and-other-muscle-wasting-disorders-301712612.html
14 Oct 2021
// PHARMABIZ
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?